Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes

Brian Tomlinson, Miao Hu, Yuzhen Zhang, Paul Chan, Zhong Min Liu

Research output: Contribution to journalEditorialpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)1267-1271
Number of pages5
JournalExpert Opinion on Drug Metabolism and Toxicology
Issue number11
Publication statusPublished - Nov 1 2016


  • Alogliptin
  • dipeptidyl peptidase-4 inhibitors
  • empagliflozin
  • glucagon-like peptide-1 agonists
  • liraglutide
  • lixisenatide
  • saxagliptin
  • sitagliptin
  • sodium-glucose cotransporter 2 inhibitors
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this